Page last updated: 2024-08-26

1,4-dihydropyridine and Coronary Heart Disease

1,4-dihydropyridine has been researched along with Coronary Heart Disease in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	4 (80.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altura, BM; Altura, BT	1
Furberg, CD; Meyer, JV; Psaty, BM	1
Trenkwalder, P	1
Leenen, FH	2

Reviews

3 review(s) available for 1,4-dihydropyridine and Coronary Heart Disease

Article	Year
Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers. Microcirculation, endothelium, and lymphatics, 1984, Volume: 1, Issue:2 Topics: Anesthesia; Animals; Arterioles; Blood Pressure; Calcium; Calcium Channel Blockers; Cell Membrane Permeability; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Disease; Diabetes Mellitus; Dihydropyridines; Female; Humans; Hypertension; Ketamine; Magnesium; Magnesium Deficiency; Microcirculation; Muscle, Smooth, Vascular; Muscles; Nifedipine; Nisoldipine; Nitrendipine; Nutritional Requirements; Pentobarbital; Pre-Eclampsia; Pregnancy; Pyridines; Rats; Vasoconstrictor Agents; Vasodilator Agents; Venules	1984
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation, 1995, Sep-01, Volume: 92, Issue:5 Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Confidence Intervals; Coronary Disease; Depression, Chemical; Dihydropyridines; Dose-Response Relationship, Drug; Hemorrhage; Humans; Hypotension; Myocardial Contraction; Myocardial Ischemia; Nifedipine; Odds Ratio; Renin-Angiotensin System; Sympathetic Nervous System; Time Factors	1995
Clinical relevance of 24 h blood pressure control by 1,4-dihydropyridines. American journal of hypertension, 1996, Volume: 9, Issue:10 Pt 2 Topics: Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Coronary Disease; Dihydropyridines; Humans	1996

Other Studies

2 other study(ies) available for 1,4-dihydropyridine and Coronary Heart Disease

Article	Year
[Comment on the information by the Federal Drug and Medical Products Institute on "calcium channel blockers of the 1,4-dihydropyridine class"]. Der Internist, 1995, Volume: 36, Issue:7 Topics: Calcium Channel Blockers; Coronary Disease; Delayed-Action Preparations; Dihydropyridines; Drug Approval; Germany; Humans; Hypertension; Structure-Activity Relationship	1995
1,4-Dihydropyridines versus beta-blockers for hypertension: are either safe for the heart? Cardiovascular drugs and therapy, 1996, Volume: 10, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Aged; Calcium Channel Blockers; Coronary Disease; Dihydropyridines; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nifedipine; Sympathetic Nervous System	1996